• Glycosylation at Asn18 Is Essential for Ceramide Synthase 6

  2026-06-24

  This study demonstrates that glycosylation at asparagine-18 is critical for ceramide synthase 6 (CerS6) enzymatic activity, but does not influence the ER stress response. The work provides mechanistic insight into posttranslational regulation of sphingolipid biosynthesis and its downstream signaling effects, informing future experimental design in lipidomics and cell signaling research.

• Purmorphamine: Smoothened Agonist Workflows for Regenerative

  2026-06-23

  Purmorphamine stands out as a Smoothened agonist, delivering robust Hedgehog pathway activation for bone and sensory research. With precise dosing and workflow optimization, it enables reproducible osteoblast differentiation and innovative studies in both vertebrate and invertebrate systems.

• Trichostatin A (TSA): Protocols and Troubleshooting for Epig

  2026-06-23

  Trichostatin A (TSA) uniquely enables precise, reproducible HDAC inhibition and cell cycle arrest, making it a gold-standard tool for dissecting epigenetic regulation in cancer models. This guide delivers stepwise protocols, troubleshooting strategies, and translational insights that help researchers maximize the utility of TSA in both cell-based and in vivo studies.

• Pharmacokinetics of Corydalis Alkaloids in MASH Mouse Models

  2026-06-22

  This study systematically examines how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of major Corydalis saxicola Bunting alkaloids in mice. Findings reveal that disease-induced changes in hepatic enzymes and transporters significantly impact systemic and liver exposures, informing more rational dosing strategies for MASLD/MASH research.

• Alternariol in Mycotoxin Research: Protocols and Innovations

  2026-06-22

  Alternariol (AOH) is emerging as a gold-standard probe for dissecting mycotoxin-driven liver fibrosis and apoptosis in cellular and enzymatic workflows. This guide delivers actionable protocols, optimization strategies, and key insights from omics-driven studies, advancing reproducibility and real-world relevance in toxicology research.

• H-Aggregated IR-1061 NIR-II Dye Enables Enhanced Tumor PTT

  2026-06-21

  Yu et al. present a lipid-peptide nanosystem leveraging H-aggregated IR-1061 for synergistic photothermal and chemotherapeutic cancer therapy. Their approach enables efficient in vivo tumor targeting, deep-tissue NIR-II imaging, and improved photothermal conversion, offering a new paradigm for molecular imaging and therapy integration.

• Phosphatase Inhibitor Cocktail 1: Enabling Signal Fidelity i

  2026-06-20

  Explore how Phosphatase Inhibitor Cocktail 1 preserves protein phosphorylation in cardiac research. This article uniquely connects inhibitor use to mechanistic insights from recent autophagy and hypertrophy studies, guiding advanced assay design.

• 3-hydroxybutyrate (BHBA) for Reliable Cell-Based Assays

  2026-06-19

  This article guides biomedical researchers through practical lab scenarios where 3-hydroxybutyrate (BHBA, SKU M1297) addresses challenges in cell viability, metabolic modeling, and pathway interrogation. Evidence-based recommendations and protocol insights illustrate why this APExBIO compound is a trusted choice for reproducibility and mechanistic rigor.

• Aurora A Kinase Regulates Trained Immunity via SAM Metabolis

  2026-06-19

  Li et al. (2025) reveal Aurora kinase A as a crucial regulator of trained immunity through modulation of endogenous S-adenosylmethionine (SAM) metabolism. Their findings uncover mechanistic links between Aurora A activity, metabolic-epigenetic crosstalk, and inflammatory gene priming, with significant implications for cancer biology and immunometabolic research.

• TAK1 Stabilization of YAP Drives Gastric Cancer Stem Cell Re

  2026-06-18

  This study reveals that TGFβ-activated kinase 1 (TAK1) stabilizes yes-associated protein (YAP), promoting self-renewal and oncogenesis in gastric cancer stem cells (GCSCs). The findings illuminate a critical pathway in gastric cancer progression and suggest new molecular targets for overcoming chemoresistance.

• Plk1-Mediated Regulation of p31comet in Mitotic Checkpoint D

  2026-06-18

  This study elucidates how Polo-like kinase 1 (Plk1) phosphorylates p31comet, suppressing its ability to disassemble mitotic checkpoint complexes (MCC) and thereby refining the timing of anaphase onset. These mechanistic insights advance our understanding of mitotic progression and have direct implications for research targeting chromosome segregation and spindle assembly checkpoint fidelity.

• 5X Protein Loading Buffer (Reducing): Technical SDS-PAGE Use

  2026-06-17

  5X Protein Loading Buffer (Reducing) is formulated for protein sample preparation in SDS-PAGE workflows requiring thorough denaturation and disulfide bond reduction. It ensures accurate protein molecular weight separation and should not be used for non-reducing or native protein analyses.

• Nuclear cGAS-TRIM41 Pathway Suppresses L1 Retrotransposition

  2026-06-17

  This study uncovers a nuclear role for cGAS in repressing LINE-1 (L1) retrotransposition through CHK2-dependent phosphorylation and TRIM41-mediated ORF2p degradation. The findings provide new mechanistic insight into genome stability maintenance, with implications for aging and cancer research.

• ACSL4 Drives Endometrial Decidualization via Fatty Acid β-Ox

  2026-06-16

  This study uncovers a pivotal role for long-chain acyl-CoA synthetase-4 (ACSL4) in promoting endometrial decidualization, not by lipid droplet accumulation, but through activation of the fatty acid β-oxidation pathway. These findings offer mechanistic clarity for reproductive biology and suggest new directions for hormone replacement therapy and endometriosis research.

• Perospirone (SM-9018): New Frontiers in Translational Resear

  2026-06-16

  Perospirone (SM-9018 freebase) is redefining the landscape of translational neuropsychiatric and cardiovascular research. This article explores its dual role as a potent serotonin–dopamine modulator and as an unexpected inhibitor of vascular Kv1.5 channels, integrating recent mechanistic insights and practical guidance for advancing experimental models. With a focus on APExBIO’s rigor and product reliability, the discussion positions Perospirone as an essential tool for researchers seeking both mechanistic depth and translational relevance.

443 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page